- Posted
- Categories
-
- OpenSAFELY
DMARD monitoring during the COVID-19 pandemic
We describe some of our recent work investigating the impact of the COVID-19 pandemic on DMARD safety monitoring across >24 million patients’ records in England.
Latest news and views from around the Bennett Institute
We describe some of our recent work investigating the impact of the COVID-19 pandemic on DMARD safety monitoring across >24 million patients’ records in England.
Applications closed. Research Software Advocate role connecting the OpenSAFELY engineering team with researchers through coding, tutorials and community events.
Debating STAR-PUs, launching Improvement Radar to identify prescribing improvements, and research on medication reviews during COVID-19.
Applications closed. OpenSAFELY engineering vacancies for junior, senior and staff developers, a tech lead and a product manager.
In the second of a two-part blog series, pharmacists Chris Wood and Vicky Speed talk about the results of their research on medication review activity
In the first of a two-part blog series, pharmacists Chris Wood and Vicky Speed talk about designing their research on medication review activity
We’ve launched a new OpenPrescribing tool, the Improvement Radar, which makes it easy to identify organisations which have shown substantial improvement.
Applications closed. Patient and Public Involvement Engagement Lead and Epidemiologist / Health Data Scientist roles supporting OpenSAFELY research.
How we organize and plan work for our tech teams
Are you interested in doing a DPhil at the Bennett Institute? This post contains details on how to do so!.
Ben discusses the OpenSAFELY platform with fellow nerd Tim Harford
In this blog we explain some of the issues with using STAR-PUs and ask for your input on how we should use them in future.
Why prescribing analyses differ between platforms, a BNF-to-dm+d map, and updates to antibiotic and glucose test strip measures.
Details on two new papers from the Bennett Institute Research Integrity Team.
Here we describe some of our recent work investigating the impact of the COVID-19 pandemic on safe prescribing using a set of quality assured indicators across 57 million patients’ records in England
In the second of a two-part blog we explain why OpenPrescribing figures don’t always match with other prescribing data resources, due to differences in how data is presented.
In the first of a two-part blog we explain why OpenPrescribing figures don’t always match with other prescribing data resources, due to differences in the data source.
In this guest blog, Mark Green describes their latest paper using OpenSAFELY.